The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 25, 2017
Filed:
Apr. 30, 2013
Applicant:
Japanese Foundation for Cancer Research, Tokyo, JP;
Inventors:
Assignee:
JAPANESE FOUNDATION FOR CANCER RESEARCH, Tokyo, JP;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 309/30 (2006.01); C07D 405/14 (2006.01); C07D 401/14 (2006.01); C07D 311/16 (2006.01); A61K 31/37 (2006.01); A61K 31/4025 (2006.01); A61K 31/5377 (2006.01); C07D 403/14 (2006.01); C07D 407/04 (2006.01); A61K 31/4409 (2006.01); A61K 31/445 (2006.01); A61K 31/4465 (2006.01);
U.S. Cl.
CPC ...
C07D 405/14 (2013.01); A61K 31/37 (2013.01); A61K 31/4025 (2013.01); A61K 31/445 (2013.01); A61K 31/4409 (2013.01); A61K 31/4465 (2013.01); A61K 31/5377 (2013.01); C07D 311/16 (2013.01); C07D 401/14 (2013.01); C07D 403/14 (2013.01); C07D 407/04 (2013.01);
Abstract
The present invention provides a small compound targeting at TACC3. The present invention further provides a drug, particularly, an anticancer agent, comprising the small compound targeting at TACC3. A compound represented by the general formula (I) or a pharmaceutically acceptable salt, solvate, or ester derivative thereof binds to TACC3 and inhibits cell growth. Thus, these compounds can be used as drugs, particularly, anticancer agents.